CADTH | Evidence Driven
CADTH | Evidence Driven

Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: Clinical Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1151-000

Question


  1. What is the clinical effectiveness of the off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions?


Key Message

Sixteen systematic reviews (five with meta-analyses), 10 randomized controlled trials, and seven non-randomized studies were identified regarding the clinical effectiveness of off-label use of intravenous immunoglobulin for the treatment of neurological or neuromuscular conditions.


Files

Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: Clinical Effectiveness Rapid Response October 30, 2017 View PDF

Related Content

Last Updated : October 30, 2017